ArticleFrontiers in oncology2022

CD9- and CD81-positive extracellular vesicles provide a marker to monitor glioblastoma cell response to photon-based and proton-based radiotherapy.

Sara Jennrich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.